Search by Drug Name or NDC

    NDC 55513-0730-01 XGEVA 120 mg/1.7mL Details

    XGEVA 120 mg/1.7mL

    XGEVA is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amgen Inc. The primary component is DENOSUMAB.

    Product Information

    NDC 55513-0730
    Product ID 55513-730_dd914cae-07e4-4eb4-bed7-5f6ece674ee4
    Associated GPIs 30044530002030
    GCN Sequence Number 066851
    GCN Sequence Number Description denosumab VIAL 120 MG/1.7 SUBCUT
    HIC3 P4L
    HIC3 Description BONE RESORPTION INHIBITORS
    GCN 29261
    HICL Sequence Number 037012
    HICL Sequence Number Description DENOSUMAB
    Brand/Generic Brand
    Proprietary Name XGEVA
    Proprietary Name Suffix n/a
    Non-Proprietary Name denosumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 120
    Active Ingredient Units mg/1.7mL
    Substance Name DENOSUMAB
    Labeler Name Amgen Inc
    Pharmaceutical Class RANK Ligand Blocking Activity [MoA], RANK Ligand Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125320
    Listing Certified Through 2024-12-31

    Package

    NDC 55513-0730-01 (55513073001)

    NDC Package Code 55513-730-01
    Billing NDC 55513073001
    Package 1 VIAL, SINGLE-USE in 1 CARTON (55513-730-01) / 1.7 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2010-11-18
    NDC Exclude Flag N
    Pricing Information N/A